Evidence map›Paper›PMID 21917492›Full record

ArticleMolecular genetics and metabolism2011

A novel application of pattern recognition for accurate SNP and indel discovery from high-throughput data: targeted resequencing of the glucocorticoid receptor co-chaperone FKBP5 in a Caucasian population.

Linda L Pelleymounter, Irene Moon, Julie A Johnson, Alain Laederach, Matt Halvorsen, Bruce Eckloff, Ryan Abo, Sandro Rossetti

Abstract read
In one paragraph

Article in Molecular genetics and metabolism, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Stressful Newborn Memories: Pre-Conceptual,Frontiers in psychiatry · 2019
    Review
  5. Review
  6. Gene-Stress-Epigenetic Regulation of FKBP5: Clinical and Translational Implications.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Linda L PelleymounterDepartment of Pharmacology, Department of Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, MN 55905, USA. pelleymounter.linda@mayo.edu
Irene Moon
Julie A Johnson
Alain Laederach
Matt Halvorsen
Bruce Eckloff
Ryan Abo
Sandro Rossetti
Mayo Clinic · USUniversity of North Carolina at Chapel Hill · USMayo Clinic in Arizona · USMayo Clinic in Florida · US

Funding

Pharmacogenetics of Phase II Drug Metabolizing EnzymesU19GM061388 · NIGMS · MAYO CLINIC ROCHESTER · PI WEINSHILBOUM, RICHARD M. · 2010 to 2014
$15.8M
Non-coding RNA structure change in Chronic Obstructive Pulmonary DiseaseR01HL111527 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Alain T Laederach, Kevin M Weeks · 2012 to 2026
$6.6M
Multi-Scale Dynamic Modeling of RNA Folding and AssemblyR00GM079953 · NIGMS · WADSWORTH CENTER · PI LAEDERACH, ALAIN T · 2008 to 2010
$969k
Identifying Disease-Associated Mutations That Alter RNA StructureR21MH087336 · NIMH · WADSWORTH CENTER · PI CURCIO, M JOAN · 2009 to 2010
$471k
Mutations detection and classification in ADPKDR21DK083669 · NIDDK · MAYO CLINIC ROCHESTER · PI HARRIS, PETER C. · 2010 to 2011
$432k
NHLBI NIH HHS R01 HL111527NIDDK NIH HHS 1R21 DK083669-01A1NIDDK NIH HHS R21 DK083669NIGMS NIH HHS R00 GM079953NIGMS NIH HHS U19 GM061388NIGMS NIH HHS U19 GM61388NIMH NIH HHS R21 MH087336
6 · The paper itself

Abstract

The detection of single nucleotide polymorphisms (SNPs) and insertion/deletions (indels) with precision from high-throughput data remains a significant bioinformatics challenge. Accurate detection is necessary before next-generation sequencing can routinely be used in the clinic. In research, scientific advances are inhibited by gaps in data, exemplified by the underrepresented discovery of rare variants, variants in non-coding regions and indels. The continued presence of false positives and false negatives prevents full automation and requires additional manual verification steps. Our methodology presents applications of both pattern recognition and sensitivity analysis to eliminate false positives and aid in the detection of SNP/indel loci and genotypes from high-throughput data. We chose FK506-binding protein 51(FKBP5) (6p21.31) for our clinical target because of its role in modulating pharmacological responses to physiological and synthetic glucocorticoids and because of the complexity of the genomic region. We detected genetic variation across a 160 kb region encompassing FKBP5. 613 SNPs and 57 indels, including a 3.3 kb deletion were discovered. We validated our method using three independent data sets and, with Sanger sequencing and Affymetrix and Illumina microarrays, achieved 99% concordance. Furthermore we were able to detect 267 novel rare variants and assess linkage disequilibrium. Our results showed both a sensitivity and specificity of 98%, indicating near perfect classification between true and false variants. The process is scalable and amenable to automation, with the downstream filters taking only 1.5h to analyze 96 individuals simultaneously. We provide examples of how our level of precision uncovered the interactions of multiple loci, their predicted influences on mRNA stability, perturbations of the hsp90 binding site, and individual variation in FKBP5 expression. Finally we show how our discovery of rare variants may change current conceptions of evolution at this locus.

Indexed as

High-Throughput Nucleotide SequencingINDEL MutationPattern Recognition, AutomatedPolymorphism, Single Nucleotide3' Untranslated RegionsAlgorithmsBase SequenceComputer SimulationGenetic VariationHaplotypesHumansLinkage DisequilibriumModels, GeneticNucleic Acid ConformationResponse ElementsRNA Stability3' Untranslated RegionsTacrolimus Binding Protein 5Tacrolimus Binding Proteins

Identifiers

PMID21917492
PMCPMC3224211
OpenAlexW2091487622

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.